Dan Cong

Changchun, 130033, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

TOP2A, BUB1B, CENPF, KIF15 and MELK: Key senescence-related genes linked to prognosis and immune infiltration in lung adenocarcinoma.

TOP2A, BUB1B, CENPF, KIF15 and MELK: Key senescence-related genes linked to prognosis and immune infiltration in lung adenocarcinoma.

Journal: International journal of biological macromolecules
Published: August 18, 2025

Evolution of conditioning regimens prior to autologous stem cell transplantation in lymphoma patients.

Evolution of conditioning regimens prior to autologous stem cell transplantation in lymphoma patients.

Journal: Translational oncology
Published: June 27, 2025

The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma.

The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma.

Journal: Scientific reports
Published: February 06, 2025

Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation.

Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation.

Journal: Scientific reports
Published: August 18, 2024

Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials.

Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials.

Journal: Critical reviews in oncology/hematology
Published: April 05, 2024

BeEAM vs. BEAM: evaluating conditioning regimens for autologous stem cell transplantation in patients with relapsed or refractory DLBCL.

BeEAM vs. BEAM: evaluating conditioning regimens for autologous stem cell transplantation in patients with relapsed or refractory DLBCL.

Journal: Annals of hematology
Published: February 18, 2024

Applying machine learning algorithms to develop a survival prediction model for lung adenocarcinoma based on genes related to fatty acid metabolism.

Applying machine learning algorithms to develop a survival prediction model for lung adenocarcinoma based on genes related to fatty acid metabolism.

Journal: Frontiers in pharmacology
Published: July 18, 2023

Case report: long-term sustained remission in a case of metastatic colon cancer with high microsatellite instability and KRAS exon 2 p.G12D mutation treated with fruquintinib after local radiotherapy: a case report and literature review.

Case report: long-term sustained remission in a case of metastatic colon cancer with high microsatellite instability and KRAS exon 2 p.G12D mutation treated with fruquintinib after local radiotherapy: a case report and literature review.

Journal: Frontiers in pharmacology
Published: April 17, 2023

Immune-related adverse events as independent prognostic factors for camrelizumab in patients with esophageal squamous cell carcinoma: a retrospective cohort study.

Immune-related adverse events as independent prognostic factors for camrelizumab in patients with esophageal squamous cell carcinoma: a retrospective cohort study.

Journal: Journal of gastrointestinal oncology
Published: December 26, 2022

Detection and clinical significance of serum EPO levels in patients with haematological tumours.

Detection and clinical significance of serum EPO levels in patients with haematological tumours.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: October 21, 2022

Correction to: HOXA11‑AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR‑124 expression by binding to EZH2.

Correction to: HOXA11‑AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR‑124 expression by binding to EZH2.

Journal: Human cell
Published: September 17, 2021

MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route.

MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route.

Journal: Bioengineered
Published: July 16, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026